Clinical trial
Predictive Urodynamic Parameters for The Treatment Efficacy of Onabotulinum A Toxin in Neurogenic Lower Urinary Tract Dysfunction
NCT06485453 is registered in ClinicalTrials.gov with University of Gaziantep as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predictive Urodynamic Parameters for The Treatment Efficacy of Onabotulinum A Toxin in Neurogenic Lower Urinary Tract Dysfunction
- Lead sponsor
- University of Gaziantep
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 1, 2013
- Completion date
- June 1, 2024
- Enrollment
- 74 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
neurogenic bladder disorder